Hint mode is switched on Switch off
For swift navigation between sections

Intellia Therapeutics
LEI 5493002T5BCPE5DZC723

PDF download

Choose all Reset all
Download Cancel
Organization name
Intellia Therapeutics Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Awards

News

09/06/2026 Intellia Therapeutics: Submission Of Matters To A Vote Of Security Holders
28/04/2026 Intellia (NTLA) Stock: Citigroup Reiterates 'Outperform' on BLA
28/04/2026 Intellia Therapeutics (NASDAQ: NTLA) Price Target Soars on Landmark Phase 3 CRISPR Gene Therapy Success
27/04/2026 Intellia Therapeutics: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Financial Statements And Exhibits
02/03/2026 Intellia Therapeutics: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    5493002T5BCPE5DZC723
  • SIC
    2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001652130
  • EIN
    36-4785571
Registration is required to get access.